Navigation Links
Poniard Pharmaceuticals Reports Third Quarter 2008 Financial Results and Corporate Update
Date:10/30/2008

expenses increased 21 percent to $3.4 million for the third quarter of 2008, from $2.8 million for the third quarter of 2007. G&A expenses increased 32 percent to $11.3 million for the nine months ended September 30, 2008, from $8.6 million for the same period in 2007. The increases in G&A expenses for the three months ended September 30, 2008, were due primarily to higher stock-based compensation expense, higher costs for consultants and increased legal costs. The increases in G&A expenses for the nine months ended September 30, 2008, are due primarily to stock-based compensation expense and increased personnel costs.

2008 Goals and Objectives

During the remainder of 2008 and into 2009, we anticipate further important progress in the development of picoplatin. We intend to:

-- Continue to advance our pivotal Phase 3 SPEAR trial in SCLC toward commercialization, targeted in 2010;

-- Announce final top-line data from our Phase 1 oral picoplatin study; and

-- Present additional efficacy and safety data from our ongoing Phase 2 trials in CRC and HRPC at medical conferences in 1Q09 and throughout next year.

Conference Call Details

To participate in today's live 2 p.m. Pacific Time/5 p.m. Eastern Time call by telephone, please dial 877-419-6593 from the U.S. or 1-719-325-4885 for international callers. In addition, the live conference call is being webcast and can be accessed on the "Events" page of the "News & Events" section of the Company's website at http://www.poniard.com. A replay of the webcast will be available on the Company's website for 10 days.

About Poniard Pharmaceuticals

Poniard Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative oncology products to impact the lives of people with cancer. Picoplatin, the Company's lead platform product candidate, is a new generation platinum thera
'/>"/>

SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Poniard Pharmaceuticals Announces Upcoming Conference Participation
2. Poniard Pharmaceuticals Reports Second Quarter 2008 Financial Results and Corporate Update
3. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
4. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
5. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
6. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
7. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
8. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
9. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
10. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
11. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2013)... Studies from Johns Hopkins University reveal ... weight and their inability to get adequate sleep. These ... can naturally relieve many symptoms. , Johns Hopkins ... quality was significantly associated with overall weight loss, especially ... dated November 6th, 2012, researchers monitored 77 participants who ...
(Date:5/25/2013)... York (PRWEB) May 25, 2013 Pradaxa ... suffered serious, life-threatening episodes of internal bleeding while using the ... in U.S. District Court, Southern District of Illinois, Bernstein Liebhard ... website, 818 Pradaxa side effect claims had been ... That’s up from 705 claims reported by the Court on ...
(Date:5/25/2013)... According to a new market report,"Global Homeland ... MarketsandMarkets is expected to reach $544.02 Billion by ... and studies the major market drivers, restraints, and ... of the World. , Browse:, , ... 87 Figures , 175 Pages and ...
(Date:5/25/2013)... Acuity Games ’ innovative brain games have come ... Hunt is available today, expanding it beyond its iPad ... Sudoku and Matchematics will roll out over the next 30 ... brain fitness measurement have been re-optimized for the iPhone's 3.5 ... fitness measurement in your pocket. What could be better?” ...
(Date:5/25/2013)... 2013 For college students, few ... Increasingly, they are turning to prescription stimulants like ... For more on this, go to http://www.sciencedaily.com/releases/2013/05/130501145151.htm ... warns that students who pick up Adderall, “just ... for developing a physical and psychological dependency. While ...
Breaking Medicine News(10 mins):Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offers Newly Improved hCG Diet Plans Capable of Delivering Better Sleep 2Health News:Pradaxa Lawsuits Mount, as Filings in Federal Pradaxa Side Effect Litigation Exceed 800, Bernstein Liebhard LLP Reports 2Health News:Pradaxa Lawsuits Mount, as Filings in Federal Pradaxa Side Effect Litigation Exceed 800, Bernstein Liebhard LLP Reports 3Health News:Homeland Security Market to Reach $544.02 Billion by 2018 at a CARC of 5.54% - New Report by MarketsandMarkets 2Health News:Homeland Security Market to Reach $544.02 Billion by 2018 at a CARC of 5.54% - New Report by MarketsandMarkets 3Health News:Homeland Security Market to Reach $544.02 Billion by 2018 at a CARC of 5.54% - New Report by MarketsandMarkets 4Health News:Acuity Games Apps Come to the iPhone 2Health News:Addiction and Drug Abuse: Study Drug Adderall Abuse Spikes During Finals 2
... Steven Reinberg HealthDay Reporter , THURSDAY, March 10 (HealthDay ... -- or even five cups -- daily may be reducing their ... research shows. And women who don,t drink coffee at all ... researchers noted. However, the researchers added, these findings are preliminary ...
... will find Major League pitchers practicing their pitches, perfecting ... grueling 162 game season. A new study published in ... for Psychological Science, suggests that hurlers might also consider ... brains. The study, led by researchers from Duke ...
... Man,s best friend may provide more than just faithful companionship: ... shows people who owned and walked their dogs were 34 ... The results, said epidemiologist Mathew Reeves, show that promoting ... of which fewer than half meet recommended levels of leisure-time ...
... HealthDay Reporter , THURSDAY, March 10 (HealthDay News) -- ... advantage these days often turn to what,s been nicknamed ... young minds. But researchers and pediatricians have begun ... these videos. And new studies are finding that the ...
... March 10, 2011 In an effort to improve ... cancer, the TGen Foundation today joined with key donors ... The backbone of globalCure is an alliance between ... includes leading pancreatic cancer scientists, physicians and researchers, armed ...
... -- You may have a higher long-term risk of disease ... in rats suggests. U.K. researchers found that rats were ... were malnourished while they were pregnant. The study was published ... Academy of Sciences . , , In the study, a ...
Cached Medicine News:Health News:Can Coffee Cut a Woman's Stroke Risk? 2Health News:Can Coffee Cut a Woman's Stroke Risk? 3Health News:Pitchers bean more batters in the heat of the summer 2Health News:Grab the leash: Dog walkers more likely to reach exercise benchmarks 2Health News:Popular Baby Media May Not Actually Advance Learning 2Health News:Popular Baby Media May Not Actually Advance Learning 3Health News:TGen Foundation launches 'globalCure,' targets pancreatic cancer 2Health News:Poor Diet in Pregnancy Tied to Disease in Offspring: Rat Study 2
(Date:5/23/2013)... , May 23, 2013  MGC Diagnostics Corporation ... global medical technology company, today scheduled a conference call ... of fiscal year 2013, ended April 30, 2013. The ... May 30, 2013. The Company will report financial results ... the markets close on Thursday, May 30, 2013. ...
(Date:5/23/2013)... KNOXVILLE, Tenn. , May 23, 2013 /PRNewswire/ ... of 24-hour nurse triage and nurse advice lines, ... 10-person committee, comprising physician, nursing and administrative leaders, ... providing safe, quality and cost-effective services for hospital ... "As our national healthcare system evolves, it,s imperative ...
(Date:5/23/2013)... IRVINE, Calif. , May 23, 2013 ... breast cancer may not benefit from chemotherapy and still ... announced the launch of one of the largest sources ... The new website and interactive Facebook page provide recently ... if they can safely avoid chemotherapy. "We ...
Breaking Medicine Technology:MGC Diagnostics Corporation to Report Second Quarter Fiscal 2013 Financial Results on Thursday, May 30, 2013 2TeamHealth Medical Call Center Forms Clinical Advisory Committee 2Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 2Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 3
... Sept. 7 Epeius Biotechnologies Corporation, a leader in ... publication of a landmark paper in clinical oncology. Following ... of Rexin-G in chemo-resistant metastatic pancreatic cancer ( Molecular ... Drug and FDA Fast Track Status, this new paper ...
... India, Sept. 7 Sun Pharmaceutical Industries Ltd. (Sun) ... today announced that the Supreme Court of Israel has ... (Taro) (Pink Sheets: TAROF ) of the ... the Israeli special tender offer (STO) rules do not ...
Cached Medicine Technology:To Reach, Perchance to Kill the Cancer: A Soliloquy From Epeius Nanotechnologies Opposes That 'Sea of Troubles' 2Supreme Court of Israel Rules in Favor of Sun Pharma 2Supreme Court of Israel Rules in Favor of Sun Pharma 3
... monitoring for flexible care settings., ... combine portability and measurement flexibility to ... of intermediate care environmentsat the patients ... heritage in patient monitoring, IntelliVue has ...
... hospital-grade monitoring capabilities into the growing health ... state management. The system is unique ... range of clinical applications, from continuous real-time ... periodic monitoring of patients outside the hospital, ...
Generra Focus 5 is a basic vital sign monitor. , ,Adult, pediatric, and neonatal. , ,Providing high quality, affordable products for efficiency in patient care....
... The Acuity Central Monitoring Station ... for up to 60 patients from ... interface uses simple point and click ... trackball. The clinician can initiate or ...
Medicine Products: